awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26768266-6C6873E6-1451-47A9-86C9-263264F3B7DB
Q26768266-6C6873E6-1451-47A9-86C9-263264F3B7DB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26768266-6C6873E6-1451-47A9-86C9-263264F3B7DB
Advancing clinical development pathways for new CFTR modulators in cystic fibrosis
P2860
Q26768266-6C6873E6-1451-47A9-86C9-263264F3B7DB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26768266-6C6873E6-1451-47A9-86C9-263264F3B7DB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fc8624e5d326ff072ef7571581baf7800d5fc1a0
P2860
A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial.